Industries > Pharma > Global Defibrillators Market Forecast 2019-2029

Global Defibrillators Market Forecast 2019-2029

External Defibrillators, Implantable Cardioverter Defibrillators, Transvenous ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators

PUBLISHED: 19 December 2018
PAGES: 179
PRODUCT CODE: PHA0348
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
SKU: PHA0348 Categories: , Tags: , ,

The global defibrillators market is expected to grow at a CAGR of 5.2% from 2017-2022. The market is expected to grow at a CAGR of 6.1% from 2017 to 2029. In 2018, the Implantable Cardioverter Defibrillators segment held 77% of the global defibrillators market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand-new report, you find 179-page report you will receive 74 tables and 125 figures – all unavailable elsewhere.

The 179-page report provides clear detailed insight into the global defibrillators market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Defibrillators Market forecast 2019-2029

• Global Defibrillators market forecast by product:

• Implantable Cardioverter Defibrillators (ICDs)
• Transvenous ICDs (T-ICDs)
– Single-Chamber ICDs
– Dual-Chamber ICDs
– Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)

• Subcutaneous ICDs (S-ICDs)

• External Defibrillators
• Manual External Defibrillators

• Automated External Defibrillators (AEDs)
– Semi-Automated External Defibrillators
– Fully-Automated External Defibrillators

• Wearable Cardioverter Defibrillators (WCDs)

• Global Defibrillators market forecast by end-user:
• Hospitals and Cardiac Centers
• Pre-hospital Services
• Public Access
• Home Care
• Other-End User

• Global Defibrillators National Market forecast 2019-2029, covering:

• North America
• US
• Canada

• Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

• Asia-Pacific:
• Japan
• China
• India
• Rest of Asia-Pacific

• Rest of the World
• Latin America
• Middle East
• Africa

Global Defibrillators Market Forecast 2019-2029

• Analysis of the key factors driving and restraining the growth of the defibrillators market

• Assessment of selected leading companies, examining recent performance and outlooks:
• Abbott Laboratories
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardiac Science Corporation
• LivaNova PLC
• Medtronic PLC
• Nihon Kohden Corporation
• Phillips Healthcare
• Physio Control Inc.
• Zoll Medical Corporation

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Defibrillators Market and leading companies. You find data, trends and predictions.

Buy our report today Global Defibrillators Market Forecast 2019-2029: External Defibrillators, Implantable Cardioverter Defibrillators, Transvenous ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Defibrillators Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Defibrillators Market Forecast 2019-2029


Latest Pharma news

Visiongain Publishes Rare Diseases Market Report 2021-2031

As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.

02 March 2021

READ

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

READ

Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031

The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.

22 February 2021

READ

Visiongain Publishes Big Data Analytics in Healthcare Market Report to 2031

The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.

22 February 2021

READ

Categories